A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
about
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical useCryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura.Investigational drugs in thrombotic thrombocytopenic purpura.Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.Type of plasma preparation used for plasma exchange and clinical outcome of adult patients with acquired idiopathic thrombotic thrombocytopenic purpura: a French retrospective multicenter cohort study.A single-center prospective study on the safety of plasma exchange procedures using a double-viral-inactivated and prion-reduced solvent/detergent fresh-frozen plasma as the replacement fluid in the treatment of thrombotic microangiopathy.Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials.Component pathogen inactivation: a critical review.Inactivation of enveloped virus by laser-driven protein aggregation.Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System™Randomized controlled trials in therapeutic apheresis.Update on the use of pathogen-reduced human plasma and platelet concentrates.Plasma treated with amotosalen and ultraviolet A light retains activity for hemostasis after 5 days post-thaw storage at 1 to 6o C.Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates.Quantitative and qualitative analysis of coagulation factors in cryoprecipitate prepared from fresh-frozen plasma inactivated with amotosalen and ultraviolet A light.Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers.Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.Inactivation of Middle East respiratory syndrome-coronavirus in human plasma using amotosalen and ultraviolet A light.Hemostatic properties and protein expression profile of therapeutic apheresis plasma treated with amotosalen and ultraviolet A for pathogen inactivation.
P2860
Q26741073-E3C11E27-F6EF-46A7-81F8-484499781F0FQ33376161-70567A89-3F81-410D-96F7-46FBAEEEC55EQ33395696-7617A93C-A120-4175-A09A-2A13BA0F40C7Q33401403-3BDB3655-C26D-42C8-BA64-94D7F5A268CBQ33424405-E2E15C37-3FB9-4D51-A04A-F865D3D3C049Q33436241-D1D27512-4FE8-4E73-922B-857D669CD0A9Q34132303-E775D6E7-0790-4099-8692-EDA77C3752DCQ34310415-1D98CB2D-946E-4902-9799-761BED968BA7Q34504426-B091D1AC-B742-4EE2-AE41-A4B4AB6377F0Q35095646-93C6B578-A56F-4E3B-904E-29E41BE89851Q38078306-46C8F2B0-912C-4E3F-9591-686253F725CAQ38109665-46B95E40-08E5-49C5-BB97-018D3030DA56Q40354711-445F0FD3-E001-4DBA-B056-A3877483F2BAQ42792674-7FEE2EDD-8499-4DA1-90BD-345B9799FE42Q46662847-54B0B9E7-AC30-4AED-8210-A656E8BC0A13Q46808805-3148868D-876D-4FA7-A51D-8AE57382C14CQ46978173-B58F7E75-3A33-4D78-A7B0-950BD1B1288BQ47312219-567BA02A-E6AD-48F0-B6D3-F60E65F15A6DQ51725959-2EE7FC8E-8CD8-47EA-B772-D7C8370B3B56
P2860
A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A randomized, controlled Phase ...... otic thrombocytopenic purpura.
@ast
A randomized, controlled Phase ...... otic thrombocytopenic purpura.
@en
type
label
A randomized, controlled Phase ...... otic thrombocytopenic purpura.
@ast
A randomized, controlled Phase ...... otic thrombocytopenic purpura.
@en
prefLabel
A randomized, controlled Phase ...... otic thrombocytopenic purpura.
@ast
A randomized, controlled Phase ...... otic thrombocytopenic purpura.
@en
P2093
P2860
P1433
P1476
A randomized, controlled Phase ...... otic thrombocytopenic purpura.
@en
P2093
Barry S Skikne
Charles Rouault
Christopher Hillyer
Craig Kessler
Ileana Lopez-Plaza
James George
Jay E Menitove
Jin-Sying Lin
Keith McCrae
P2860
P304
P356
10.1111/J.1537-2995.2006.00959.X
P577
2006-10-01T00:00:00Z